Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
CALL
Ventas
VTR
$44.7B
| $4.7M | ﹤0.01% |
99,500
+22,000
| +28% | +$997K |
|
|
AMAM
2677
DELISTED
Ambrx Biopharma Inc
AMAM
| $4.7M | ﹤0.01% |
285,716
+274,727
| +2,500% | +$3.45M |
|
2678
Riskified
RSKD
$701M
| $4.7M | ﹤0.01% |
966,820
+283,295
| +41% | +$1.42M |
|
2679
CALL
AMC Entertainment Holdings
AMC
$2.47B
| $4.7M | ﹤0.01% |
106,760
-59,030
| -36% | -$2.92M |
|
|
EXK
2680
Endeavour Silver
EXK
$2.3B
| $4.69M | ﹤0.01% |
1,621,488
+201,184
| +14% | +$711K |
|
2681
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $4.69M | ﹤0.01% |
332,746
-293,452
| -47% | -$3.93M |
|
|
INBX
2682
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $4.68M | ﹤0.01% |
180,348
-539,205
| -75% | -$12.6M |
|
|
HOLI
2683
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $4.68M | ﹤0.01% |
+265,922
| New | +$4.35M |
|
2684
iShares Floating Rate Bond ETF
FLOT
$10.2B
| $4.68M | ﹤0.01% |
92,026
+22,926
| +33% | +$1.16M |
|
2685
PUT
BILL Holdings
BILL
$4.52B
| $4.67M | ﹤0.01% |
+40,000
| New | +$3.8M |
|
|
IBTX
2686
DELISTED
Independent Bank Group, Inc.
IBTX
| $4.67M | ﹤0.01% |
135,333
+49,570
| +58% | +$1.84M |
|
2687
Invesco Leisure and Entertainment ETF
PEJ
$260M
| $4.66M | ﹤0.01% |
111,527
+34,100
| +44% | +$1.39M |
|
2688
Avita Medical
RCEL
$138M
| $4.66M | ﹤0.01% |
274,097
-61,379
| -18% | -$901K |
|
|
K
2689
CALL
DELISTED
Kellanova
K
| $4.66M | ﹤0.01% |
73,592
-1,065
| -1% | -$67.9K |
|
|
ESPR
2690
DELISTED
Esperion Therapeutics
ESPR
| $4.65M | ﹤0.01% |
3,346,726
-328,548
| -9% | -$459K |
|
|
CCVI
2691
DELISTED
Churchill Capital Corp VI
CCVI
| $4.63M | ﹤0.01% |
449,998
-583,252
| -56% | -$5.95M |
|
2692
Piper Sandler
PIPR
$5.15B
| $4.63M | ﹤0.01% |
143,304
+118,276
| +473% | +$3.91M |
|
|
EXAS
2693
PUT
DELISTED
Exact Sciences
EXAS
| $4.63M | ﹤0.01% |
+49,300
| New | +$3.85M |
|
|
KCGI
2694
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
| $4.63M | ﹤0.01% |
438,172
| – | – |
|
2695
Cato Corp
CATO
$66.5M
| $4.61M | ﹤0.01% |
574,608
-161,011
| -22% | -$1.34M |
|
2696
CALL
Motorola Solutions
MSI
$71.5B
| $4.6M | ﹤0.01% |
15,700
+14,700
| +1,470% | +$4.21M |
|
2697
CALL
KKR & Co
KKR
$90.7B
| $4.59M | ﹤0.01% |
81,900
+61,900
| +310% | +$3.24M |
|
2698
Ryder
R
$9.9B
| $4.58M | ﹤0.01% |
53,995
+34,923
| +183% | +$2.88M |
|
2699
Alto Ingredients
ALTO
$358M
| $4.58M | ﹤0.01% |
1,583,471
+1,444,209
| +1,037% | +$2.75M |
|
2700
Interface
TILE
$1.96B
| $4.57M | ﹤0.01% |
520,268
-414,716
| -44% | -$3.18M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.